Statement Of Comprehensive Income [Abstract]

Xbrane Biopharma - Filing #679208

Concept	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31
Statement of comprehensive income [abstract]
Profit (loss)	—	—	388 172 SEK	388 172 SEK	—	—	172 513 SEK	172 513 SEK	—	—
Other comprehensive income [abstract]
Components of other comprehensive income that will be reclassified to profit or loss, before tax [abstract]
Cost of hedging [abstract]
Change in value of foreign currency basis spreads [abstract]
Gains (losses) on change in value of foreign currency basis spreads, before tax	—	—	201,000 SEK	—	—	—	5 157 SEK	—	—	—
Other comprehensive income	—	—	201,000 SEK	—	201,000 SEK	—	5 157 SEK	—	5 157 SEK	—
Comprehensive income	0 SEK	0 SEK	388 373 SEK	388 172 SEK	201,000 SEK	– SEK	167 356 SEK	172 513 SEK	5 157 SEK	– SEK
Comprehensive income attributable to [abstract]
Comprehensive income, attributable to non-controlling interests	—	—	– SEK	—	—	—	– SEK	—	—	—